BLUE NOTE THERAPEUTICS
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise. The company works with medical researchers and patient advocacy organizations to provide prescriptions to any patient using their mobile devices. Blue Note Therapeutics was founded in 2018 and is based in San Francisco, California.
BLUE NOTE THERAPEUTICS
Social Links:
Industry:
Health Care Health Diagnostics Medical Therapeutics
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.bluenotetherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
415-200-3697
Email Addresses:
[email protected]
Total Funding:
46.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Current Employees Featured
Founder
Investors List
Jazz Venture Partners
Jazz Venture Partners investment in Series A - Blue Note Therapeutics
Memorial Sloan - Kettering Cancer Center
Memorial Sloan - Kettering Cancer Center investment in Series A - Blue Note Therapeutics
Alumni Ventures
Alumni Ventures investment in Series A - Blue Note Therapeutics
Summer VC
Summer VC investment in Series A - Blue Note Therapeutics
Summer VC
Summer VC investment in Series A - Blue Note Therapeutics
Jazz Venture Partners
Jazz Venture Partners investment in Series A - Blue Note Therapeutics
Official Site Inspections
http://www.bluenotetherapeutics.com Semrush global rank: 2.16 M Semrush visits lastest month: 9.23 K
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Blue Note Therapeutics"
Blue Note Therapeutics - Crunchbase Company Profile & Funding
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise. The company works with medical researchers and patient advocacy …See details»
Blue Note Therapeutics - Overview, News & Similar companies
Aug 22, 2022 Blue Note Therapeutics contact info: Phone number: (415) 200-3697 Website: www.bluenotetherapeutics.com What does Blue Note Therapeutics do? Blue Note …See details»
Blue Note Therapeutics Raises $26.25 Million in Series A Financing
SAN FRANCISCO, March 3, 2021 /PRNewswire/ -- Blue Note Therapeutics, Inc., today announced the closing of a Series A financing round of $26.25 million.Proceeds will allow the …See details»
Blue Note Therapeutics | LinkedIn
Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to helping patients live better. Blue Note is merging deep scientific and clinical expertise with digital ...See details»
Blue Note Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Blue Note Therapeutics, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Blue Note Therapeutics · GitHub
Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to transforming mental health care for cancer patients. - Blue Note TherapeuticsSee details»
Blue Note Therapeutics - PitchBook
Jan 1, 2018 Information on valuation, funding, cap tables, investors, and executives for Blue Note Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Blue Note Therapeutics - Digital Therapeutics Alliance
Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to serving patients suffering from cancer. We aim to make treatment accessible to any cancer …See details»
Blue Note Therapeutics | VentureRadar
Working closely with leading cancer centers, community oncology clinics, and teams of patients, Blue Note is developing clinically validated... ... Find out more ...See details»
Blue Note Therapeutics - Products, Competitors, Financials, …
Blue Note's application for Breakthrough Device status was supported by positive usability and preliminary efficacy findings. Blue Note Therapeutics will retain commercialization rights for …See details»
Blue Note Therapeutics Announces New Collaboration for its …
Sep 14, 2021 To date, Blue Note has raised a total of $31 million in Series A financing, allowing the company to scale the organization and fund a pipeline of evidence-based therapeutics to …See details»
Blue Note Therapeutics Enters Licensing Agreement With …
Feb 3, 2022 Blue Note's plans comprise product research and design, engineering, user testing, including clinical trials, and commercialization. The territory for this licensing agreement …See details»
Blue Note Therapeutics Receives Breakthrough Device Designation …
Jan 6, 2022 The FDA Breakthrough Designation is granted to novel medical devices that have the potential to provide more effective treatment or diagnosis of life-threatening or irreversibly …See details»
OncoHealth and Blue Note Therapeutics Partner to Provide a …
May 31, 2022 For more information, visit www.bluenotetherapeutics.com. About OncoHealth OncoHealth is a leading digital health company dedicated to helping health plans, employers, …See details»
Blue Note Therapeutics Raises $5.2M in Additional Series A Funding
SAN FRANCISCO, Sept. 9, 2021 /PRNewswire/ -- Blue Note Therapeutics raised an additional $5.2 million in Series A financing, bringing the company's Series A financing to a total of $31 …See details»
The Oncology Institute Partners with Blue Note Therapeutics to …
CERRITOS, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United …See details»
OncoHealth and Blue Note Therapeutics Partner to Provide a …
May 31, 2022 Through OncoHealth's telehealth platform, Iris™, licensed healthcare professionals can provide Blue Note's attune™ to patients living with cancer.See details»
Recommended Stories - Yahoo Finance
May 10, 2022 DreAMLand, the second of the two licensed products, is a first-of-its-kind prescription-only digital therapeutic to treat anxiety and depressive symptoms in adults with …See details»
OncoHealth and Blue Note Therapeutics Partner to Provide a
SAN FRANCISCO, May 31, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics, a prescription digital therapeutics (PDT) company dedicated to easing the burden of cancer and improving …See details»